Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
27.87
+0.27 (0.98%)
Feb 4, 2026, 3:15 PM EST - Market open
Enliven Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$41.00
Upside
+47.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $48 | Strong Buy | Maintains | $40 → $48 | +72.23% | Jul 2, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +32.76% | Jun 16, 2025 |
| Baird | Baird | Buy Maintains $40 → $52 | Buy | Maintains | $40 → $52 | +86.58% | Jun 16, 2025 |
| Jones Trading | Jones Trading | Strong Buy Maintains $36 → $27 | Strong Buy | Maintains | $36 → $27 | -3.12% | May 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +43.52% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $39 | Strong Buy | Maintains | $37 → $39 | +39.94% | Mar 21, 2025 |
| BTIG | BTIG | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +50.70% | Dec 13, 2024 |
| Baird | Baird | Buy Maintains $32 → $40 | Buy | Maintains | $32 → $40 | +43.52% | Nov 15, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +29.17% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +32.76% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +32.76% | Sep 9, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +14.82% | Jun 11, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +21.99% | Apr 9, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | -3.12% | Mar 29, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |